D-0010-2023 Class II
FDA drug recall D-0010-2023 was initiated by Ingenus Pharmaceuticals Llc on Sep 30, 2022 and is designated Class II. Reason for recall: Out of specification for related substances (impurities). Affected quantity: 6176 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 26, 2022
- Initiation Date
- Sep 30, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6176 bottles
Product description
Flunisolide Nasal Solution, USP 0.025%, 25 mL bottles, Rx only, Manufactured for: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408; NDC 50742-317-25 UPC 3 50742 31725 7
Reason for recall
Out of specification for related substances (impurities).
Distribution pattern
Nationwide within the United States
Code information
Lot #: 22E040 Exp. 07/2023; 22F038 Exp. 08/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0010-2023
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026